Table 3.
Testing Labs No. (%) | Referring Labs No. (%) | p-value | |
Geographic location | |||
Metropolitan/central city | 11/17 (64.7) | 13/40 (32.5) | 0.024 |
Metropolitan/suburban | 4/17 (23.5) | 9/40 (22.5) | 1.000* |
Small city/town | 2/17 (11.8) | 16/40 (40.0) | 0.036 |
Rural | 0/17 (0) | 2/40 (5.0) | 1.000* |
Size of catchment area | |||
0 – 500,000 | 2/16 (12.5) | 21/37 (56.8) | 0.003 |
500,000 – 2,000,000 | 8/16 (50.0) | 13/37 (35.1) | 0.310 |
Greater than 2,000,000 | 6/16 (37.5) | 3/37 (8.1) | 0.016* |
Type of setting | |||
Community hospital | 3/16 (18.8) | 26/38 (68.4) | 0.001 |
Academic Health Science Centre | 11/16 (68.8) | 12/38 (31.6) | 0.012 |
Research laboratory | 2/16 (12.5) | 0/38 (0) | 0.084* |
Type of laboratory | |||
General pathology | 1/16 (6.3) | 22/38 (57.9) | < 0.001 |
Anatomical pathology | 1/16 (6.3) | 9/38 (23.7) | 0.249* |
Hematopathology | 2/16 (12.5) | 0/38 (0) | 0.084* |
Hematology | 1/16 (6.3) | 3/38 (7.9) | 1.000* |
Cancer cytogenetics | 1/16 (6.3) | 0/38 (0) | 1.000* |
Cytology | 0/16 (0) | 2/38 (5.3) | 1.000* |
Flow cytometry | 0/16 (0) | 2/38 (5.3) | 1.000* |
Cytogenetics | 5/16 (31.3) | 0/38 (0) | 0.001* |
Molecular cancer genetics | 1/16 (6.3) | 0/38 (0) | 0.296* |
Molecular genetics | 4/16 (25.0) | 0/38 (0) | 0.006* |
* Fisher exact test